quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 21, 2026

Stock market today: Dow surges 550 points, S&P 500, Nasdaq jump as Trump backs off Greenland tariff threats

View original at finance.yahoo.com
Stock market today: Dow surges 550 points, S&P 500, Nasdaq jump as Trump backs off Greenland tariff threats US stocks spiked on Wednesday after President Trump announced the US and NATO "formed the framework of a future deal" on Greenland and called off threatened tariffs on European nations, just days after he roiled…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Asking Congress to cap credit card interest rates at 10% for one year

    80% confidence
  • Netflix is confident in Warner Bros. Discovery acquisition approval

    80% confidence
  • 10% credit card interest rate cap would cause economic disaster

    80% confidence
  • Not worried about AI bubble, real businesses are growing

    80% confidence
  • Interest rate cap would force banks to cancel credit lines for large swath of Americans

    80% confidence
  • US and NATO formed framework of future deal on Greenland and Arctic region

    80% confidence
  • Dimon declares himself a globalist

    80% confidence
  • Credit card company profit margins now exceed 50%

    80% confidence
  • US makes greatest weapons in world, will now make them faster

    80% confidence
  • AI spending fears are not well founded

    80% confidence
  • Intel manufacturing business has quite a ways to go

    80% confidence
  • Credit card issuers currently charge 28-32% interest rates

    80% confidence
  • AI company valuations decreased in 2025, not a bubble

    80% confidence
  • Trillions of dollars of AI infrastructure needs to be built

    80% confidence
  • Will not impose tariffs scheduled for February 1st due to Greenland deal framework

    80% confidence
  • Moderna continues to invest in oncology platform due to encouraging outcomes

    80% confidence
  • Seeking immediate negotiations on Greenland, won't use force to gain control

    80% confidence
  • America will not become a nation of renters

    80% confidence
  • Working with Congress on crypto market structure legislation to keep America as crypto capital

    80% confidence
  • All money going into stock buybacks for defense contractors will go into building plants

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com